We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWL icon
201
Newell Brands
NWL
$2.56B
$458K 0.2%
84,897
+12,091
+17% +$64.1K
FICO icon
202
Fair Isaac
FICO
$22.5B
$457K 0.2%
250
-34
-12% -$63.8K
ONTO icon
203
Onto Innovation
ONTO
$15.3B
$456K 0.2%
+4,517
New +$482K
PNW icon
204
Pinnacle West Capital
PNW
$12.2B
$454K 0.2%
5,073
-4,493
-47% -$411K
PRVA icon
205
Privia Health
PRVA
$2.87B
$453K 0.2%
19,690
+8,686
+79% +$201K
AIZ icon
206
Assurant
AIZ
$14.3B
$453K 0.2%
+2,293
New +$451K
O icon
207
Realty Income
O
$59.1B
$452K 0.2%
+7,851
New +$444K
OKTA icon
208
Okta
OKTA
$25.8B
$452K 0.2%
4,522
-453
-9% -$48.4K
FAF icon
209
First American
FAF
$7.58B
$451K 0.2%
7,345
-6,866
-48% -$408K
MKSI icon
210
MKS Inc
MKSI
$20.6B
$445K 0.19%
+4,482
New +$364K
TT icon
211
Trane Technologies
TT
$106B
$444K 0.19%
1,015
-1,587
-61% -$626K
TXN icon
212
Texas Instruments
TXN
$261B
$440K 0.19%
2,118
+869
+70% +$154K
MAT icon
213
Mattel
MAT
$4.23B
$438K 0.19%
+22,236
New +$396K
DDOG icon
214
Datadog
DDOG
$84B
$436K 0.19%
3,246
-762
-19% -$84.4K
KEY icon
215
KeyCorp
KEY
$24.4B
$434K 0.19%
+24,942
New +$387K
IPAR icon
216
Interparfums
IPAR
$3.94B
$434K 0.19%
3,305
+908
+38% +$111K
SCI icon
217
Service Corp International
SCI
$11.6B
$431K 0.19%
+5,300
New +$414K
SWK icon
218
Stanley Black & Decker
SWK
$15.7B
$431K 0.19%
+6,356
New +$410K
PCTY icon
219
Paylocity
PCTY
$7.98B
$430K 0.19%
+2,374
New +$446K
R icon
220
Ryder
R
$10.1B
$429K 0.19%
2,697
+898
+50% +$132K
AMZN icon
221
Amazon
AMZN
$2.96T
$426K 0.19%
+1,942
New +$384K
MTZ icon
222
MasTec
MTZ
$21.9B
$426K 0.18%
2,499
-6,575
-72% -$947K
GNTX icon
223
Gentex
GNTX
$5.07B
$424K 0.18%
19,294
+8,675
+82% +$190K
GM icon
224
General Motors
GM
$76.8B
$424K 0.18%
+8,617
New +$408K
ETSY icon
225
Etsy
ETSY
$7.85B
$424K 0.18%
8,447
-2,363
-22% -$118K
7 8
9
10 11

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.